cyclosporine and Cardiovascular Stroke

cyclosporine has been researched along with Cardiovascular Stroke in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (7.34)	18.2507
2000's	36 (33.03)	29.6817
2010's	60 (55.05)	24.3611
2020's	5 (4.59)	2.80

Authors

Authors	Studies
Andreadou, I; Bibli, SI; Fotopoulou, T; Iliodromitis, EK; Koufaki, M; Kremastinos, DT; Zoga, A	1
Abate, A; Amici, R; Ballarini, M; Bernardi, P; Cappa, A; Carenzi, G; Colombo, A; Contursi, C; Di Lisa, F; Dondio, G; Fancelli, D; Gagliardi, S; Milanesi, E; Minucci, S; Pain, G; Pelicci, PG; Plyte, S; Saccani, A; Storto, M; Thaler, F; Varasi, M; Villa, M	1
Akande, O; Chen, Q; Cholyway, R; Lesnefsky, EJ; Quader, M; Toldo, S	1
Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H	1
Bednarczyk, P; Bopassa, JC; Feng, Y; GururajaRao, S; Hussain, AT; Khan, M; Meka, J; Ponnalagu, D; Singh, H; Szewczyk, A; Thanawala, R	1
Bryant, A; Chadwick, T; Cormack, S; Das, R; Egred, M; Mohammed, A; Panahi, P; Spyridopoulos, I; Steel, AJ; Stellos, K	1
Aliazadeh, S; Alizadeh, AM; Amiriani, T; Dehpour, A; Enayati, A; Ensan, PS; Jafarzadeh, F; Jand, Y; Khori, V; Mazaheri, Z; Moheimani, HR; Pourabouk, M; Pourkhani, AH; Rajaei, M; Shakiba, D; Zeyghami, MA	1
Feige, K; Heinen, A; Hollmann, MW; Huhn, R; Raupach, A; Ruske, R; Stroethoff, M; Torregroza, C; Yueksel, B	1
Bulluck, H; Cabrera-Fuentes, HA; Campbell-Washburn, AE; Dongworth, RK; Hausenloy, DJ; Hernández-Reséndiz, S; Lythgoe, MF; Ordidge, RJ; Price, AN; Roberts, T; Thomas, DL; Yellon, DM	1
Alexopoulos, P; Dougenis, D; Koletsis, E; Panoutsopoulou, K; Tsopanoglou, NE; Vogiatzis, G	1
Chen, J; Chen, Q; Cheng, H; Hu, X; Huang, J; Jiang, Y; Kong, M; Li, Q; Li, Y; Liang, H; Ni, C; Tao, Z; Wang, J; Wang, Y; Wu, Q; Wu, Y; Xu, Y; Yang, HT; Yang, Q; Yu, H; Zhang, F; Zhang, J; Zhang, P; Zhao, J; Zhong, Z; Zhu, K; Zhu, W	1
Chen, ZY; Huang, Y; Qiang, W; Rusinkevich, V; Shi, YF; Wang, YG; Yang, HT	1
Augeul, L; Belaidi, E; Decorps, J; Durand, A; Ovize, M	1
Abrial, M; Argaud, L; Chiari, P; Couture-Lepetit, E; De Paulis, D; Gharib, A; Ovize, M; Teixeira, G	1
Pei, ZY; Wang, H; Yin, QX; Zhao, YS	1
Dey, D; Diecke, S; Ebert, A; Gold, JD; Gong, Y; Hu, S; Huber, BC; Kodo, K; Kooreman, NG; Odegaard, J; Ransohoff, JD; Ransohoff, KJ; Riegler, J; Robbins, RC; Sanchez-Freire, V; Wu, JC; Zhang, WY	1
Hu, J; Kholmukhamedov, A; Lemasters, JJ; Logdon, C; McKinney, RA; Mukherjee, R; Spinale, FG	1
Pei, Z; Wang, H; Yin, Q; Zhao, Y	1
Javadov, S	1
Kholmukhamedov, A; Lemasters, JJ; Mukherjee, R; Spinale, FG	1
Andreadou, I; Dagres, N; Iliodromitis, EK; Iliodromitis, K	1
Ahlehoff, O; Bryld, LE; Gislason, G; Gniadecki, R; Hansen, PR; Iversen, L; Kristensen, SL; Lasthein, S; Lindhardsen, J; Skov, L; Torp-Pedersen, C	1
Bogaert, J; Buszman, P; Claus, P; Driesen, RB; Driessche, NV; Galan, DT; Milewski, K; Sipido, KR; Van de Werf, F; Zalewski, J	1
Angoulvant, D; Aupetit, JF; Barragan, P; Beard, T; Belle, L; Blanchard, D; Bonnefoy-Cudraz, E; Boussaha, I; Cayla, G; Claeys, M; Clerc, J; Colin, P; Coste, P; Cottin, Y; Coussement, P; Cung, TT; Delarche, N; Dubois, P; Dubois-Randé, JL; Elbaz, M; Elmer, E; Garcia-Dorado, D; Gilard, M; Grollier, G; Guerin, P; Hansson, MJ; Ider, O; Jossan, C; Jouve, B; Labeque, JN; Lebreton, H; Malquarti, V; Metge, M; Mewton, N; Monassier, JP; Morel, O; Morice, MC; Motreff, P; Moulin, F; Ovize, M; Piot, C; Prunier, F; Range, G; Rioufol, G; Roth, O; Staat, P; Steg, PG; Sudre, A; Torner, A; Tron, C; Unterseeh, T; Vanzetto, G	1
Qi, D; Song, K; Wang, S	1
Angoulvant, D; Aupetit, JF; Barragan, P; Béard, T; Belle, L; Bergerot, C; Blanchard, D; Bonnefoy-Cudraz, E; Boussaha, I; Cayla, G; Claeys, MJ; Clerc, J; Colin, P; Coste, P; Cottin, Y; Coussement, P; Cung, TT; De Poli, F; Delarche, N; Derumeaux, G; Dubois, P; Dubois-Randé, JL; Elbaz, M; Elmer, E; Garcia-Dorado, D; Gilard, M; Grollier, G; Guérin, P; Hansson, MJ; Ider, O; Jossan, C; Jouve, B; Labeque, JN; Le Breton, H; Malquarti, V; Metge, M; Mewton, N; Morel, O; Morice, MC; Motreff, P; Moulin, F; Ovize, M; Piot, C; Prunier, F; Range, G; Rioufol, G; Roth, O; Staat, P; Steg, PG; Sudre, A; Tron, C; Unterseeh, T; Vanzetto, G	1
Hausenloy, DJ; Yellon, DM	2
Lim, GB	1
Kitsis, RN; Konstantinidis, K; Linkermann, A	1
Bergerot, C; Mewton, N; Ovize, M	1
Badimon, JJ; Santos-Gallego, CG	1
Diemunsch, P; Geny, B; Pottecher, J	1
Katritsis, DG; Zografos, TA	1
Bernardi, P; Di Lisa, F	1
Barlera, S; Boi, A; Costalunga, A; De Cesare, N; La Vecchia, L; Latini, R; Limbruno, U; Locuratolo, N; Lombardi, M; Maggioni, AP; Masson, S; Milani, V; Mollichelli, N; Ottani, F; Santarelli, A; Sganzerla, P; Sicuro, M; Staszewsky, L	1
Chen-Scarabelli, C; Scarabelli, TM	1
Behmenburg, F; Blase, D; Dorsch, M; Grievink, H; Heinen, A; Hollmann, MW; Huhn, R; Raible, M	1
Cho, TH; Mewton, N; Nighoghossian, N; Ong, E; Ovize, M	1
Nicholls, M	1
Bachuwa, G; Baniya, R; Madala, S; Saginala, K; Subedi, SK; Upadhaya, S	1
Alihemmati, A; Azimi, A; Badalzadeh, R; Yousefi, B	1
Deleuran, MS; Hjuler, KF; Iversen, L; Jakobsen, L; Olsen, M; Riis, JL; Vestergaard, C	1
Almeida, AM; Muus, P; Schrezenmeier, H; Urbano-Ispizua, Á; Ware, RE; Wilson, A	1
Barbosa, RA; Brasil, GV; Brito, JO; Campos de Carvalho, AC; Carvalho, AB; Costa, AR; Cunha, ST; Farjun, B; Kasai-Brunswick, TH; Mesquita, FC; Passipieri, JD; Ramos, IP; Silva Dos Santos, D; Suhett, G	1
Ahmed, AI; Avkiran, M; Clark, JE; Davidson, SM; Jacquet, S; Marber, MS; Miura, T; Nishino, Y; Shah, AM; Webb, IG; Yellon, DM	1
André-Fouët, X; Angoulvant, D; Bonnefoy, E; Croisille, P; Cung, TT; Derumeaux, G; Elbelghiti, R; Finet, G; Gahide, G; Kirkorian, G; Macia, C; Mewton, N; Monassier, JP; Ovize, M; Piot, C; Raczka, F; Revel, D; Rioufol, G; Sportouch, C; Staat, P; Thibault, H	1
Gorman, JH; Gorman, RC; Hinmon, R; Kanemoto, S; Leshnower, BG; Matsubara, M; Sakamoto, H	1
Lemasters, JJ; Theruvath, TP	1
Rossi, JS; Simpson, RJ	1
Badimon, JJ; Ibanez, B	1
Hoffman, I	1
Ryding, AD	1
Elbaz, M; Gomez, L; Li, B; Mewton, N; Ovize, M; Piot, C; Sanchez, I	1
Krolikowski, JG; Pagel, PS	1
Colantuono, G; Di Venosa, N; Fiore, T; Moro, N; Paradies, G; Petrosillo, G; Ruggiero, FM; Tiravanti, E	1
Chang, LT; Chua, S; Fu, M; Sheu, JJ; Sun, CK; Wu, CJ; Yen, CH; Yip, HK	1
Brudek, M; Czarnowska, E; Klemenska, E; Konior, A; Lewartowski, B; Mackiewicz, U; Maczewski, M	1
Escoto, H; Kalpatthi, R; Ringewald, J	1
Heusch, G; Schulz, R; Skyschally, A	1
André-Fouët, X; Angoulvant, D; Bonnefoy, E; Croisille, P; Cung, TT; Derumeaux, G; Finet, G; Gahide, G; Mewton, N; Ovize, M; Piot, C; Revel, D; Rioufol, G; Sanchez, I; Sportouch, C; Vernhet, H	1
Akita, G; Chen, R; He, C; Larson, S; Molnar, G; O'Callaghan, M; Seleznik, G; Stewart, J; Wadsworth, S; Wentworth, B; Westrich, J; Yaeger, P	1
Chance, B; Gorman, JH; Gorman, RC; Leshnower, BG; Matsubara, M; Noma, M; Ranji, M; Ratcliffe, SJ	1
Akyürek, LM; Aström-Olsson, K; Grip, L; Karlsson, LO; Larsson, E; Månsson, C; Zhou, AX	1
Hasenkam, JM; Kroyer, R; Lie, RH; Nielsen, TT; Sloth, E; Stoettrup, N	1
Ivanes, F; Ovize, M; Piot, C; Rioufol, G	1
Croisille, P; Elbaz, M; Ivanes, F; Mewton, N; Ovize, M; Piot, C; Revel, D; Rioufol, G	1
Argaud, L; Cour, M; Gomez, L; Mewton, N; Ovize, M	1
Arjun, S; Davidson, SM; Hausenloy, DJ; Lim, SY; Lythgoe, MF; Price, AN; Yellon, DM	1
Bergh, N; Grip, L; Karlsson, LO	1
Brink, PR; Glass, PS; Liu, L; Rebecchi, MJ; Zhu, J	1
Ahmadiasl, N; Badalzadeh, R; Ebrahimi, H; Farajnia, S; Mohammadi, M; Najafi, M	1
Berry, C; Lim, WY; Messow, CM	1
Figueredo, VM; Kaneda, K; Kotani, J; Miyamae, M; Onishi, A	1
Inui, M; Shintani-Ishida, K; Yoshida, K	1
Allamargot, C; Anderson, ME; Chen, B; Fink, BD; Gao, Z; Hall, DD; He, BJ; Joiner, ML; Koval, OM; Li, J; Luczak, ED; Mohler, PJ; Moore, SA; Scholz, TD; Sivitz, WI; Song, LS; Strack, S; Yang, J	1
Brown, JH; Dalton, N; Gray, CB; Grimm, M; Gu, Y; Ling, H; Peterson, K; Purcell, NH; Zambon, AC	1
Akbari, H; Benet, LZ; Christians, U; Jacobsen, W; Niemann, CU; Saeed, M; Serkova, N	1
Cho, MC; Choi, SY; Kim, DW; Kim, HS; Kim, YG; Kwon, JS; Park, DG; Piao, H; Youn, TJ	1
Achterhuis, A; Becker, AE; Biezeveld, M; Hack, CE; Kuijpers, TW; Kuipers, I; Lam, J; van der Wal, AC	1
Argaud, L; Chalabreysse, L; Gateau-Roesch, O; Gomez, L; Loufouat, J; Ovize, M; Robert, D; Thivolet-Béjui, F	1
Chase, EG; Minami, E; Murry, CE; Rossow, CF; Santana, LF	1
Argaud, L; Gateau-Roesch, O; Loufouat, J; Ovize, M; Raisky, O; Robert, D	1
Argaud, L; Chalabreysse, L; Gateau-Roesch, O; Loufouat, J; Muntean, D; Ovize, M; Robert, D	1
Argaud, L; Chalabreysse, L; Chavanis, N; Gateau-Roesch, O; Gomez, L; Ninet, J; Ovize, M	1
Bruce, IC; Cao, CM; Gao, Q; Xia, Q; Zhang, SZ	1
Kotyla, PJ; Kucharz, EJ; Lewicki, M; Sliwińska-Kotyla, B	1
Serón, D	1
Alam, S; Arnaout, MS; Dimasi, A; Harb, R	1
Bache, RJ; Boozer, S; Deans, R; Feygin, J; From, AH; Hu, Q; Lee, J; Mansoor, A; Mhashilkar, A; Panetta, CJ; Suntharalingam, P; Swingen, C; Verfaillie, CM; Wang, X; Zeng, L; Zhang, G; Zhang, J	1
Christians, U; Haschke, M; Kaisers, U; Laudi, S; Schmitz, V; Steudel, W; Trump, S; Weimann, J	1
Derumeaux, G; Dumont, JM; Gharib, A; Gomez, L; Ovize, M; Scalfaro, P; Thibault, H; Vuagniaux, G	1
Aoyama, T; Esaki, M; Fujiwara, H; Fujiwara, T; Kanamori, H; Kawasaki, M; Maruyama, R; Minatoguchi, S; Miyata, S; Nakagawa, M; Ogino, A; Okada, H; Takemura, G; Ushikoshi, H	1
Argaud, L; Augeul, L; Couture-Lepetit, E; Gateau-Roesch, O; Gomez, L; Loufouat, J; Ovize, M; Robert, D	1
Guo, C; Haider, HKh; Jiang, S; Law, PK; Shim, WS; Sim, EK; Tan, RS; Wong, P; Ye, L	1
Heinen, A; Hollmann, MW; Huhn, R; Preckel, B; Schlack, W; Weber, NC	1
Bettiol, E; Dubois-Dauphin, M; He, Q; Herrmann, F; Jaconi, ME; Kalangos, A; Li, J; Morel, D; Stumm, M; Trindade, PT; Zammaretti, P	1
Mozaffari, MS; Schaffer, SW	1
Derumeaux, G; Gomez, L; Ovize, M; Paillard, M; Thibault, H	1
Akiyama, K; Bing, RJ; Cannavino, C; Grant, P; Horstman, D; Suzuki, H; Wolf, WP	1
Agostini, C; Biasiolo, A; De Silvestro, G; Livi, U; Marson, P; Pengo, V	1
Cohen, MV; Downey, JM; Liu, GS; Weinbrenner, C	1
Baxter, GF; Cai, Q; Yellon, DM	1
Detry, O; Honoré, P; Jacquet, N; Meurisse, M	1
Altavilla, D; Arlotta, M; Campo, GM; Caputi, AP; Ferlito, M; Quartarone, C; Saitta, A; Squadrito, F; Squadrito, G	1
Attramadal, H; Bjørnerheim, R; Clausen, OP; Oie, E	1
Deng, L; El-Sherif, N; Ganguly, K; Huang, B; Qin, D	1
Geró, S; Horváth, M; Jósfay, A; Mezey, Z; Nánay, I; Varsányi, M	1

Reviews

11 review(s) available for cyclosporine and Cardiovascular Stroke

Article	Year
Emergency and critical care medicine, 2022, Volume: 2, Issue:3 Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling	2022
Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials. Oxidative medicine and cellular longevity, 2015, Volume: 2015 Topics: Creatine Kinase; Creatine Kinase, MB Form; Cyclosporine; Databases, Factual; Humans; Magnetic Resonance Imaging; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Radiography; Randomized Controlled Trials as Topic; Troponin I; Ventricular Function, Left	2015
Cyclosporine A, a Potential Therapy of Ischemic Reperfusion Injury. A Common History for Heart and Brain. Cerebrovascular diseases (Basel, Switzerland), 2016, Volume: 42, Issue:5-6 Topics: Animals; Brain; Brain Ischemia; Cyclosporine; Disease Models, Animal; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Neuroprotective Agents; Signal Transduction; Stroke	2016
Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: A meta-analysis. Cardiology journal, 2017, Volume: 24, Issue:1 Topics: Cyclosporine; Echocardiography; Humans; Immunosuppressive Agents; Myocardial Infarction; Myocardial Reperfusion Injury	2017
Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovascular research, 2009, Jul-15, Volume: 83, Issue:2 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiotonic Agents; Cyclosporine; Humans; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Time Factors; Treatment Outcome	2009
Postconditioning in acute myocardial infarction patients. Antioxidants & redox signaling, 2011, Mar-01, Volume: 14, Issue:5 Topics: Acute Disease; Animals; Cyclosporine; Enzyme Inhibitors; Humans; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion Injury	2011
Cardioprotection in the clinical setting. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:3 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiotonic Agents; Cyclosporine; Humans; Ischemic Postconditioning; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Time Factors	2010
Postconditioning: from the bench to bedside. Journal of cardiovascular pharmacology and therapeutics, 2011, Volume: 16, Issue:2 Topics: Animals; Cyclosporine; Disease Models, Animal; Humans; Ischemic Postconditioning; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury	2011
Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis. British journal of pharmacology, 2012, Volume: 165, Issue:7 Topics: Animals; Cardiotonic Agents; Cyclosporine; Disease Models, Animal; Humans; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Rats; Species Specificity; Swine; Treatment Outcome	2012
Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect. Pediatrics, 2003, Volume: 112, Issue:4 Topics: Aneurysm; C-Reactive Protein; Coronary Disease; Cyclosporine; Cytokines; Drug Resistance; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Salicylates; Serine Endopeptidases	2003
[Risk of atherosclerosis development in patients with systemic lupus erythematosus]. Polskie Archiwum Medycyny Wewnetrznej, 2005, Volume: 114, Issue:5 Topics: Adrenal Cortex Hormones; Arteriosclerosis; Autoantibodies; Azathioprine; Blood Coagulation Disorders; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Disease Progression; Female; Humans; Lupus Erythematosus, Systemic; Myocardial Infarction; Risk Factors	2005

Trials

7 trial(s) available for cyclosporine and Cardiovascular Stroke

Article	Year
Emergency and critical care medicine, 2022, Volume: 2, Issue:3 Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling	2022
Effect of ciclosporin on safety, lymphocyte kinetics and left ventricular remodelling in acute myocardial infarction. British journal of clinical pharmacology, 2020, Volume: 86, Issue:7 Topics: Cyclosporine; Double-Blind Method; Humans; Kinetics; Lymphocytes; Magnetic Resonance Imaging; Myocardial Infarction; Treatment Outcome; Ventricular Remodeling	2020
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial). American heart journal, 2015, Volume: 169, Issue:6 Topics: Biomarkers; Coronary Angiography; Cyclosporine; Double-Blind Method; Echocardiography; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Time Factors; Treatment Outcome	2015
Cyclosporine before PCI in Patients with Acute Myocardial Infarction. The New England journal of medicine, 2015, Sep-10, Volume: 373, Issue:11 Topics: Aged; Combined Modality Therapy; Cyclophilins; Cyclosporine; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Female; Heart Failure; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2015
Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial. Journal of the American College of Cardiology, 2016, Feb-02, Volume: 67, Issue:4 Topics: Coronary Angiography; Cyclosporine; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Prospective Studies; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2016
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. The New England journal of medicine, 2008, Jul-31, Volume: 359, Issue:5 Topics: Angioplasty, Balloon, Coronary; Area Under Curve; Biomarkers; Combined Modality Therapy; Creatine Kinase; Cyclosporine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Pilot Projects; Premedication; Single-Blind Method; Troponin I	2008
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. Journal of the American College of Cardiology, 2010, Mar-23, Volume: 55, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cyclosporine; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Time Factors; Treatment Outcome; Ventricular Remodeling	2010

Other Studies

92 other study(ies) available for cyclosporine and Cardiovascular Stroke

Article	Year
Discovery of 6-[4-(6-nitroxyhexanoyl)piperazin-1-yl)]-9H-purine, as pharmacological post-conditioning agent. Bioorganic & medicinal chemistry, 2012, Oct-01, Volume: 20, Issue:19 Topics: Animals; Cardiotonic Agents; Heart; Hemodynamics; Ischemic Postconditioning; Myocardial Infarction; Myocardium; Nitrates; Purines; Rabbits	2012
Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo. Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12 Topics: 1-Naphthylamine; Acrylamides; Anilides; Animals; Calcium; Cinnamates; Female; Male; Mice, Inbred C57BL; Mitochondria, Heart; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Stereoisomerism; Structure-Activity Relationship	2014
Infarct Size With Incremental Global Myocardial Ischemia Times: Cyclosporine A in Donation After Circulatory Death Rat Hearts. Transplantation proceedings, 2023, Volume: 55, Issue:7 Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart; Heart Transplantation; Myocardial Infarction; Rats; Tissue Donors	2023
Chloride channel blocker IAA-94 increases myocardial infarction by reducing calcium retention capacity of the cardiac mitochondria. Life sciences, 2019, Oct-15, Volume: 235 Topics: Animals; Calcium; Cyclosporine; Dose-Response Relationship, Drug; Glycolates; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardial Infarction; Rats	2019
Preconditioning and anti-apoptotic effects of Metformin and Cyclosporine-A in an isolated bile duct-ligated rat heart. European journal of pharmacology, 2021, Feb-15, Volume: 893 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Apoptosis Regulatory Proteins; Bile Ducts; Cardiomyopathies; Cyclosporine; Cytoprotection; Enzyme Activation; Hemodynamics; Ischemic Preconditioning, Myocardial; Isolated Heart Preparation; Ligation; Liver Cirrhosis, Experimental; Male; Metformin; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Signal Transduction	2021
Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia. International journal of molecular sciences, 2021, Apr-26, Volume: 22, Issue:9 Topics: Animals; Cardiotonic Agents; Cyclosporine; Disease Models, Animal; Heart; Hyperglycemia; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Simendan	2021
Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance. Scientific reports, 2017, 05-23, Volume: 7, Issue:1 Topics: Animals; Cyclosporine; Disease Models, Animal; Heart Ventricles; Image Processing, Computer-Assisted; Ischemic Preconditioning, Myocardial; Magnetic Resonance Imaging; Male; Mice; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium	2017
Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit Model. Journal of cardiovascular pharmacology, 2017, Volume: 70, Issue:1 Topics: Animals; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Exenatide; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Peptide Fragments; Peptides; Rabbits; Receptor, PAR-1; Venoms	2017
Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates. Circulation research, 2018, 03-30, Volume: 122, Issue:7 Topics: Animals; Cell Line; Cyclosporine; Human Embryonic Stem Cells; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Macaca fascicularis; Male; Muscle Development; Myoblasts, Cardiac; Myocardial Infarction; Stem Cell Transplantation	2018
Temporal dynamics of immune response following prolonged myocardial ischemia/reperfusion with and without cyclosporine A. Acta pharmacologica Sinica, 2019, Volume: 40, Issue:9 Topics: Animals; Chemokines; Cyclosporine; Human Umbilical Vein Endothelial Cells; Humans; Immunity, Cellular; Killer Cells, Natural; Lymph Nodes; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neovascularization, Physiologic; Neutrophils; T-Lymphocytes; Time Factors; Ventricular Remodeling	2019
Endoplasmic reticulum stress contributes to heart protection induced by cyclophilin D inhibition. Basic research in cardiology, 2013, Volume: 108, Issue:4 Topics: Animals; Cyclophilins; Cyclosporine; Cyclosporins; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heart; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Membranes; Myocardial Infarction; Myocardial Reperfusion Injury; Peptidyl-Prolyl Isomerase F; Taurochenodeoxycholic Acid	2013
Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic research in cardiology, 2013, Volume: 108, Issue:5 Topics: Anesthetics, Inhalation; Animals; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar	2013
[Efficacy of cyclosporine A-nanoparticles emulsion combined with stem cell transplantation therapy for acute myocardial infarction]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2013, Volume: 35, Issue:4 Topics: Adipocytes; Animals; Caspase 3; Cyclosporine; Disease Models, Animal; Myocardial Infarction; Nanoparticles; Random Allocation; Stem Cell Transplantation; Swine	2013
Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation. Stem cells (Dayton, Ohio), 2013, Volume: 31, Issue:11 Topics: Abatacept; Animals; Antibodies, Monoclonal; Cardiotonic Agents; Cell Differentiation; Cyclosporine; Embryonic Stem Cells; Endothelial Cells; Graft Rejection; Humans; Immune Tolerance; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Mice, Inbred NOD; Mice, SCID; Myocardial Infarction; Prednisone; Random Allocation	2013
Cyclosporin A in left ventricular remodeling after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2014, Jan-01, Volume: 306, Issue:1 Topics: Administration, Oral; Animals; Apoptosis; Cyclosporine; Electrocardiography; Mice; Mice, Inbred C57BL; Myocardial Infarction; Stroke Volume; Ventricular Remodeling	2014
Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model. International journal of nanomedicine, 2014, Volume: 9 Topics: Adipocytes; Animals; Combined Modality Therapy; Cyclosporine; Immunosuppressive Agents; Male; Myocardial Infarction; Nanocapsules; Particle Size; Stem Cell Transplantation; Swine; Treatment Outcome	2014
Letter to the editor: "cyclosporin A in left ventricular remodeling after myocardial infarction". American journal of physiology. Heart and circulatory physiology, 2014, Mar-01, Volume: 306, Issue:5 Topics: Animals; Cyclosporine; Myocardial Infarction; Ventricular Remodeling	2014
Reply to "letter to the editor: 'cyclosporin A in left ventricular remodeling after myocardial infarction'". American journal of physiology. Heart and circulatory physiology, 2014, Mar-01, Volume: 306, Issue:5 Topics: Animals; Cyclosporine; Myocardial Infarction; Ventricular Remodeling	2014
Ischemic and postischemic conditioning of the myocardium in clinical practice: challenges, expectations and obstacles. Cardiology, 2014, Volume: 129, Issue:2 Topics: Adenosine; Cyclosporine; Enzyme Activators; Erythropoietin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nicorandil; Vasodilator Agents	2014
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents; Biological Products; Cardiovascular Diseases; Cause of Death; Climatotherapy; Cyclosporine; Denmark; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Myocardial Infarction; Phototherapy; Psoriasis; Registries; Retinoids; Severity of Illness Index; Stroke; Tumor Necrosis Factor-alpha; Ustekinumab	2015
Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion. Basic research in cardiology, 2015, Volume: 110, Issue:2 Topics: Animals; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Female; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Swine	2015
Targeting Myocardial Reperfusion Injury--The Search Continues. The New England journal of medicine, 2015, Sep-10, Volume: 373, Issue:11 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2015
Pharmacotherapy: Lack of benefit of cyclosporine to attenuate reperfusion injury after PCI. Nature reviews. Cardiology, 2015, Volume: 12, Issue:11 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2015
Catch me if you can: targeting the mitochondrial permeability transition pore in myocardial infarction. Cell death and differentiation, 2016, Volume: 23, Issue:1 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2016
Cyclosporine before PCI in Acute Myocardial Infarction. The New England journal of medicine, 2016, 01-07, Volume: 374, Issue:1 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2016
Cyclosporine before PCI in Acute Myocardial Infarction. The New England journal of medicine, 2016, 01-07, Volume: 374, Issue:1 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2016
Cyclosporine before PCI in Acute Myocardial Infarction. The New England journal of medicine, 2016, 01-07, Volume: 374, Issue:1 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2016
Cyclosporine before PCI in Acute Myocardial Infarction. The New England journal of medicine, 2016, 01-07, Volume: 374, Issue:1 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2016
Cyclosporine before PCI in Acute Myocardial Infarction. The New England journal of medicine, 2016, 01-07, Volume: 374, Issue:1 Topics: Cyclophilins; Cyclosporine; Enzyme Inhibitors; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling	2016
Cyclosporine A Prior to Primary PCI in STEMI Patients: The Coup de Grâce to Post-Conditioning? Journal of the American College of Cardiology, 2016, Feb-02, Volume: 67, Issue:4 Topics: Cyclosporine; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Myocardial Reperfusion; Ventricular Function, Left; Ventricular Remodeling	2016
Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore. PloS one, 2016, Volume: 11, Issue:3 Topics: Animals; Atractyloside; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Energy Metabolism; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoquinolines; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Morphine; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Random Allocation; Rats, Wistar; Reperfusion; Signal Transduction; STAT3 Transcription Factor; Sulfonamides	2016
CardioPulse: Cyclosporine to reduce myocardial infarction injury? European heart journal, 2016, Jan-14, Volume: 37, Issue:3 Topics: Chemokine CX3CL1; Cyclosporine; Heart Failure; Humans; Immunosuppressive Agents; Lymphocytes; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention	2016
Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury. Journal of physiology and biochemistry, 2017, Volume: 73, Issue:1 Topics: Animals; Apoptosis; Biomarkers; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Heart; Immunosuppressive Agents; In Vitro Techniques; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Random Allocation; Rats, Wistar; Streptozocin	2017
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study. BMJ open, 2016, 11-11, Volume: 6, Issue:11 Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, Atopic; Eczema; Female; Follow-Up Studies; Hospitalization; Hospitals; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Myocardial Infarction; Registries; Risk Factors; Young Adult	2016
Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients. Haematologica, 2017, Volume: 102, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antilymphocyte Serum; Cerebrovascular Disorders; Child; Child, Preschool; Cyclosporine; Erythrocyte Transfusion; Female; Hemoglobinuria, Paroxysmal; Hemolysis; Heparin; Humans; Infant; Infant, Newborn; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Neutropenia; Neutrophils; Registries; Retrospective Studies; Thromboembolism; Warfarin	2017
Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure. Stem cell research & therapy, 2017, 02-15, Volume: 8, Issue:1 Topics: Animals; Coronary Occlusion; Coronary Vessels; Cyclosporine; Disease Models, Animal; Echocardiography; Heart Function Tests; Humans; Immunocompromised Host; Injections, Intralesional; Myocardial Infarction; Rats; Rats, Wistar; Spheroids, Cellular; Stem Cells; Treatment Failure	2017
Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circulation research, 2008, Aug-01, Volume: 103, Issue:3 Topics: Animals; Cardiotonic Agents; Cyclosporine; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Ischemic Preconditioning, Myocardial; Mice; Mice, Transgenic; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation	2008
Time to take myocardial reperfusion injury seriously. The New England journal of medicine, 2008, Jul-31, Volume: 359, Issue:5 Topics: Angioplasty, Balloon, Coronary; Creatine Kinase; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Premedication; Signal Transduction; Troponin I	2008
Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition. The Annals of thoracic surgery, 2008, Volume: 86, Issue:4 Topics: Analysis of Variance; Animals; Calcineurin; Cyclosporine; Disease Models, Animal; Immunohistochemistry; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Muscle; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Probability; Rabbits; Random Allocation; Sensitivity and Specificity; Tacrolimus	2008
Cyclosporine in acute myocardial infarction. The New England journal of medicine, 2008, Nov-20, Volume: 359, Issue:21 Topics: Angioplasty, Balloon, Coronary; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Premedication	2008
Cyclosporine in acute myocardial infarction. The New England journal of medicine, 2008, Nov-20, Volume: 359, Issue:21 Topics: Angioplasty, Balloon, Coronary; Bias; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction	2008
Cyclosporine in acute myocardial infarction. The New England journal of medicine, 2008, Nov-20, Volume: 359, Issue:21 Topics: Angioplasty, Balloon, Coronary; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophil Activation; Peroxidase	2008
Cyclosporine in acute myocardial infarction. The New England journal of medicine, 2008, Nov-20, Volume: 359, Issue:21 Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Cyclosporine; Electrocardiography; Humans; Microvessels; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury	2008
Cyclosporine in acute myocardial infarction. The New England journal of medicine, 2008, Nov-20, Volume: 359, Issue:21 Topics: Angioplasty, Balloon, Coronary; Animals; Cyclosporine; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Stroke Volume; Ventricular Remodeling	2008
Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits. Anesthesia and analgesia, 2009, Volume: 108, Issue:4 Topics: Acidosis; Administration, Inhalation; Alkalosis; Animals; Cyclosporine; Disease Models, Animal; Drug Administration Schedule; Helium; Hemodynamics; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Rabbits; Sodium Bicarbonate	2009
Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:4 Topics: Animals; Antioxidants; Calcium; Cardiolipins; Cardiovascular Agents; Cyclosporine; Cytochromes c; Heart Rate; In Vitro Techniques; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Melatonin; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NAD; Necrosis; Perfusion; Rats; Rats, Wistar; Recovery of Function; Time Factors; Ventricular Function, Left; Ventricular Pressure	2009
Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction. International journal of cardiology, 2011, Feb-17, Volume: 147, Issue:1 Topics: Animals; Coronary Vessels; Cyclosporine; Injections, Intra-Arterial; Male; Myocardial Infarction; Oxidative Stress; Random Allocation; Swine; Swine, Miniature; Ventricular Function, Left; Ventricular Remodeling	2011
Brief postinfarction calcineurin blockade affects left ventricular remodeling and Ca2+ handling in the rat. Journal of molecular and cellular cardiology, 2010, Volume: 48, Issue:6 Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cyclosporine; Echocardiography; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Time Factors; Ventricular Remodeling	2010
Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis. Cardiology in the young, 2010, Volume: 20, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Electrocardiography; Etoposide; Follow-Up Studies; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Myocardial Infarction; Risk Assessment; Steroids; Ventricular Remodeling; Withholding Treatment	2010
Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:1 Topics: Animals; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Cyclosporine; Female; Heart Rate; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Reperfusion; Swine; Swine, Miniature	2010
Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium. Cell transplantation, 2010, Volume: 19, Issue:8 Topics: Animals; Cell Survival; Chemokine CCL2; Cyclosporine; Genes, Reporter; Imaging, Three-Dimensional; Injections; Interleukin-6; Interleukin-8; Luciferases, Firefly; Male; Mesenchymal Stem Cell Transplantation; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic; Vascular Endothelial Growth Factors	2010
In vivo fluorometric assessment of cyclosporine on mitochondrial function during myocardial ischemia and reperfusion. The Annals of thoracic surgery, 2010, Volume: 89, Issue:5 Topics: Animals; Cyclosporine; Disease Models, Animal; Immunohistochemistry; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Rabbits; Random Allocation; Reference Values; Risk Assessment; Spectrometry, Fluorescence	2010
Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model. Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:2 Topics: Anesthetics; Animals; Apoptosis Inducing Factor; Caspase 3; Cyclosporine; Disease Models, Animal; Drug Interactions; Female; Hemodynamics; Isoflurane; Membrane Proteins; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Pentobarbital; Proto-Oncogene Proteins; Random Allocation; Swine	2010
Post-conditioning with cyclosporine A fails to reduce the infarct size in an in vivo porcine model. Acta anaesthesiologica Scandinavica, 2010, Volume: 54, Issue:7 Topics: Animals; Biomarkers; Coronary Circulation; Cyclosporine; Hemodynamics; Immunosuppressive Agents; Lactic Acid; Microdialysis; Myocardial Infarction; Myocardial Reperfusion Injury; Swine; Ventricular Fibrillation	2010
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:11 Topics: Animals; Apoptosis; Cell Proliferation; Cyclophilins; Cyclosporine; Heart Failure; Heart Ventricles; Lactones; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Peptidyl-Prolyl Isomerase F; Spiro Compounds; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2011
Cyclosporine A, 2.5 mg/kg, does not reduce myocardial infarct size in a porcine model of ischemia and reperfusion. Journal of cardiovascular pharmacology and therapeutics, 2012, Volume: 17, Issue:2 Topics: Animals; Cyclosporine; Disease Models, Animal; Female; Immunosuppressive Agents; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Swine	2012
Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A. Acta anaesthesiologica Scandinavica, 2011, Volume: 55, Issue:5 Topics: Aging; Animals; Cardiotonic Agents; Cell Separation; Cyclosporine; Hemodynamics; Image Processing, Computer-Assisted; Immunosuppressive Agents; In Vitro Techniques; Male; Microscopy, Confocal; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; Permeability; Rats; Rats, Inbred F344; Reactive Oxygen Species	2011
The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion. Journal of cardiovascular pharmacology and therapeutics, 2012, Volume: 17, Issue:2 Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Wistar; Streptozocin	2012
Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. European journal of pharmacology, 2012, Jan-30, Volume: 675, Issue:1-3 Topics: Animals; Calcium Signaling; Cardiotonic Agents; Chromones; Cyclosporine; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guinea Pigs; Immunosuppressive Agents; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Methyl Ethers; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Morpholines; Myocardial Infarction; Myocytes, Cardiac; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Sevoflurane; Ventricular Function, Left	2012
Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca²⁺ overload. Journal of molecular and cellular cardiology, 2012, Volume: 53, Issue:2 Topics: Animals; Apoptosis Inducing Factor; Calcium; Calcium-Binding Proteins; Cyclosporine; Lactones; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Ruthenium Compounds; Sarcoplasmic Reticulum; Spiro Compounds	2012
CaMKII determines mitochondrial stress responses in heart. Nature, 2012, Nov-08, Volume: 491, Issue:7423 Topics: Animals; Apoptosis; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclosporine; Female; Heart; Heart Failure; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardium; Reperfusion Injury; Serine; Stress, Physiological	2012
Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB. Circulation research, 2013, Mar-15, Volume: 112, Issue:6 Topics: Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclosporine; Gene Expression Profiling; Heart; I-kappa B Proteins; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Recovery of Function; Transcription Factor RelA; Up-Regulation	2013
Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3 Topics: Adenosine Triphosphate; Animals; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Energy Metabolism; Immunosuppressive Agents; Magnetic Resonance Spectroscopy; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Risk Assessment	2002
Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction. European journal of heart failure, 2002, Volume: 4, Issue:6 Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Enzyme Inhibitors; Heart Function Tests; Hemodynamics; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Reference Values; Signal Transduction; Time Factors; Treatment Outcome; Ventricular Remodeling	2002
Preconditioning delays Ca2+-induced mitochondrial permeability transition. Cardiovascular research, 2004, Jan-01, Volume: 61, Issue:1 Topics: Animals; Apoptosis; Calcium; Cyclosporine; Immunosuppressive Agents; In Situ Nick-End Labeling; Intracellular Membranes; Ischemic Preconditioning, Myocardial; Male; Microscopy, Electron; Mitochondria, Heart; Myocardial Infarction; Myocytes, Cardiac; Necrosis; Permeability; Rabbits; Random Allocation	2004
NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circulation research, 2004, May-28, Volume: 94, Issue:10 Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cyclosporine; DNA-Binding Proteins; Electric Conductivity; Isoproterenol; Kinetics; Metoprolol; Mice; Mice, Knockout; Myocardial Infarction; Myocytes, Cardiac; NFATC Transcription Factors; Potassium Channels, Voltage-Gated; Transcription Factors	2004
Postconditioning inhibits mitochondrial permeability transition. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Animals; Apoptosis; Calcium; Coronary Disease; Cyclosporine; Extracellular Signal-Regulated MAP Kinases; Ion Channel Gating; Ion Channels; Ion Transport; Male; MAP Kinase Signaling System; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Oxidative Stress; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rabbits; Random Allocation; Time Factors	2005
Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. Journal of molecular and cellular cardiology, 2005, Volume: 38, Issue:2 Topics: Animals; Apoptosis; Blood Pressure; Calcium; Cardiotonic Agents; Cyclosporine; Heart; Hemodynamics; Intracellular Membranes; Male; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Permeability; Rabbits	2005
Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:5 Topics: Animals; Apoptosis; Blotting, Western; Calcium; Caspase 3; Caspases; Cell Death; Cyclosporine; Cytochromes c; Enzyme Activation; fas Receptor; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Permeability	2005
The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha. Cytokine, 2005, Dec-07, Volume: 32, Issue:5 Topics: Animals; Atractyloside; Coronary Circulation; Cyclosporine; In Vitro Techniques; Ion Channels; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Permeability; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha	2005
Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3 Topics: Acenocoumarol; Amiodarone; Angioplasty; Calcineurin Inhibitors; Carbazoles; Carvedilol; Cyclosporine; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Immunosuppressive Agents; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Postoperative Complications; Pravastatin; Prednisone; Propanolamines; Risk Factors; Tacrolimus; Treatment Outcome	2006
Unusual thrombotic cardiac complications of Pemphigus vulgaris: a new link? Journal of thrombosis and thrombolysis, 2007, Volume: 23, Issue:3 Topics: Adult; Anticoagulants; Cyclosporine; Diagnostic Imaging; Heart Diseases; Heparin; Humans; Male; Myocardial Infarction; Pemphigus; Pulmonary Embolism; Steroids; Thrombosis	2007
Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation, 2007, Apr-10, Volume: 115, Issue:14 Topics: Adenosine Triphosphate; Animals; Cell Differentiation; Cell Lineage; Cyclosporine; Energy Metabolism; Female; Immunosuppressive Agents; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Models, Animal; Multipotent Stem Cells; Myocardial Contraction; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Phosphocreatine; Random Allocation; Regeneration; Sus scrofa; Swine; Ventricular Remodeling	2007
Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2007, Volume: 58, Issue:1 Topics: Animals; Cardiotonic Agents; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Organ Size; Pilot Projects; Random Allocation; Rats; Rats, Sprague-Dawley; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure	2007
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:3 Topics: Acute Disease; Animals; Calcium; Cyclosporine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Mice; Mitochondria, Heart; Myocardial Infarction; Permeability; Reperfusion Injury; Survival Analysis; Ventricular Dysfunction, Left	2007
Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Amlodipine; Animals; Apoptosis; bcl-Associated Death Protein; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Coronary Vessels; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; fas Receptor; Granulation Tissue; Hydralazine; Ligation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Phosphorylation; Research Design; Tacrolimus; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2007
Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:1 Topics: Animals; Calcium; Cardiovascular Agents; Cell Respiration; Cyclophilins; Cyclosporine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptidyl-Prolyl Isomerase F; Rabbits; Time Factors	2008
Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. The Journal of thoracic and cardiovascular surgery, 2007, Volume: 134, Issue:5 Topics: Animals; Cell Transplantation; Cyclosporine; Disease Models, Animal; Female; Heart; Humans; Immune Tolerance; Immunosuppressive Agents; Male; Myoblasts; Myocardial Infarction; Rats; Rats, Wistar; Transplantation, Heterologous; Transplantation, Homologous	2007
Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. British journal of anaesthesia, 2008, Volume: 100, Issue:4 Topics: Animals; Blood Glucose; Blood Pressure; Cardiotonic Agents; Cyclosporine; Drug Administration Schedule; Heart Rate; Hyperglycemia; Male; Methyl Ethers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Sevoflurane	2008
Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression. Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:1 Topics: Animals; Cell Differentiation; Cell Lineage; Cyclosporine; Embryonic Stem Cells; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mice; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Teratoma; Transplantation, Heterologous; Ventricular Function, Left	2009
Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore. American journal of hypertension, 2008, Volume: 21, Issue:5 Topics: Animals; Cardiotonic Agents; Cyclosporine; Diazoxide; Disease Models, Animal; Glyburide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypertension; In Vitro Techniques; Indoles; Lithium Chloride; Male; Maleimides; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Pressure	2008
Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation, 2008, May-27, Volume: 117, Issue:21 Topics: Animals; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Ischemic Preconditioning, Myocardial; Maleimides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Phosphorylation; Phosphorylation	2008
Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle. Proceedings of the Association of American Physicians, 1996, Volume: 108, Issue:2 Topics: Animals; Arginine; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Heart; Isothiuronium; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rabbits	1996
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome. Clinical rheumatology, 1996, Volume: 15, Issue:5 Topics: Adult; Antiphospholipid Syndrome; Azathioprine; Cardiomyopathy, Dilated; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Myocardial Infarction; Plasmapheresis; Preoperative Care; Treatment Failure	1996
Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovascular research, 1998, Volume: 38, Issue:3 Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cyclosporine; Enzyme Inhibitors; Female; Immunosuppressive Agents; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Rabbits; Tacrolimus	1998
Reduction of infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibition. Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:5 Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Drug Evaluation, Preclinical; Enzyme Inhibitors; In Vitro Techniques; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tacrolimus	1998
[Liver transplantation: experiences and results of a program at the University of Liege]. Revue medicale de Liege, 1998, Volume: 53, Issue:12 Topics: Actuarial Analysis; Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Belgium; Chronic Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Liver Transplantation; Myocardial Infarction; Postoperative Complications; Reoperation; Survival Rate; Tacrolimus; Time Factors; Waiting Lists	1998
Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. European journal of pharmacology, 1999, Jan-08, Volume: 364, Issue:2-3 Topics: Animals; Creatine Kinase; Cyclosporine; Disease Models, Animal; Gene Expression; Hemodynamics; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Leukocytes; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha	1999
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:6 Topics: Animals; Apoptosis; Cardiomegaly; Cyclosporine; Echocardiography; Fibrosis; Gene Expression; Heart; Heart Failure; Male; Myocardial Infarction; Myocardium; Pressure; Rats; Rats, Wistar; Renin; Ventricular Function, Left; Ventricular Remodeling	2000
Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling. Journal of cardiovascular electrophysiology, 2001, Volume: 12, Issue:9 Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Protein Phosphatase 1; Rats; Rats, Sprague-Dawley; Ventricular Remodeling	2001
[Organ transplantation]. [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1992, Volume: 40, Issue:5 Topics: Adult; Aged; Animals; Brain Death; Catheterization, Swan-Ganz; Coronary Artery Disease; Cyclosporine; Denervation; Dogs; Female; Heart; Heart Transplantation; Herpesviridae Infections; Humans; Immunosuppression Therapy; Lung; Lung Transplantation; Male; Middle Aged; Myocardial Infarction; Organ Transplantation; Postoperative Complications; Rats; Tissue Survival	1992
The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction. Journal of investigational allergology & clinical immunology, 1991, Volume: 1, Issue:6 Topics: Aged; Antigen-Antibody Complex; Aorta; Cell Migration Inhibition; Clofibric Acid; Cyclosporine; Female; Humans; Hypolipidemic Agents; Immunity, Cellular; In Vitro Techniques; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Nifedipine	1991